Diabetes Mellitus, Type 2
"Diabetes Mellitus, Type 2" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.
| Descriptor ID |
D003924
|
| MeSH Number(s) |
C18.452.394.750.149 C19.246.300
|
| Concept/Terms |
Diabetes Mellitus, Type 2- Diabetes Mellitus, Type 2
- Diabetes Mellitus, Noninsulin-Dependent
- Diabetes Mellitus, Ketosis-Resistant
- Diabetes Mellitus, Ketosis Resistant
- Ketosis-Resistant Diabetes Mellitus
- Diabetes Mellitus, Non Insulin Dependent
- Diabetes Mellitus, Non-Insulin-Dependent
- Non-Insulin-Dependent Diabetes Mellitus
- Diabetes Mellitus, Stable
- Stable Diabetes Mellitus
- Diabetes Mellitus, Type II
- NIDDM
- Diabetes Mellitus, Noninsulin Dependent
- Diabetes Mellitus, Maturity-Onset
- Diabetes Mellitus, Maturity Onset
- Maturity-Onset Diabetes Mellitus
- Maturity Onset Diabetes Mellitus
- MODY
- Diabetes Mellitus, Slow-Onset
- Diabetes Mellitus, Slow Onset
- Slow-Onset Diabetes Mellitus
- Type 2 Diabetes Mellitus
- Noninsulin-Dependent Diabetes Mellitus
- Noninsulin Dependent Diabetes Mellitus
- Maturity-Onset Diabetes
- Diabetes, Maturity-Onset
- Maturity Onset Diabetes
- Type 2 Diabetes
- Diabetes, Type 2
- Diabetes Mellitus, Adult-Onset
- Adult-Onset Diabetes Mellitus
- Diabetes Mellitus, Adult Onset
|
Below are MeSH descriptors whose meaning is more general than "Diabetes Mellitus, Type 2".
Below are MeSH descriptors whose meaning is more specific than "Diabetes Mellitus, Type 2".
This graph shows the total number of publications written about "Diabetes Mellitus, Type 2" by people in this website by year, and whether "Diabetes Mellitus, Type 2" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1993 | 6 | 1 | 7 |
| 1994 | 10 | 2 | 12 |
| 1995 | 20 | 3 | 23 |
| 1996 | 22 | 1 | 23 |
| 1997 | 18 | 3 | 21 |
| 1998 | 6 | 4 | 10 |
| 1999 | 5 | 1 | 6 |
| 2000 | 25 | 6 | 31 |
| 2001 | 11 | 4 | 15 |
| 2002 | 17 | 5 | 22 |
| 2003 | 7 | 6 | 13 |
| 2004 | 21 | 5 | 26 |
| 2005 | 24 | 4 | 28 |
| 2006 | 27 | 3 | 30 |
| 2007 | 19 | 6 | 25 |
| 2008 | 25 | 8 | 33 |
| 2009 | 17 | 9 | 26 |
| 2010 | 22 | 4 | 26 |
| 2011 | 31 | 10 | 41 |
| 2012 | 26 | 6 | 32 |
| 2013 | 32 | 4 | 36 |
| 2014 | 44 | 6 | 50 |
| 2015 | 29 | 4 | 33 |
| 2016 | 41 | 4 | 45 |
| 2017 | 24 | 6 | 30 |
| 2018 | 35 | 7 | 42 |
| 2019 | 38 | 3 | 41 |
| 2020 | 31 | 7 | 38 |
| 2021 | 47 | 4 | 51 |
| 2022 | 67 | 0 | 67 |
| 2023 | 15 | 0 | 15 |
To return to the timeline,
click here.
Below are the most recent publications written about "Diabetes Mellitus, Type 2" by people in Profiles.
-
Design of the COmbinatioN effect of FInerenone anD EmpaglifloziN in participants with chronic kidney disease and type 2 diabetes using a UACR Endpoint study (CONFIDENCE). Nephrol Dial Transplant. 2023 03 31; 38(4):894-903.
-
Polygenic risk scores for asthma and allergic disease associate with COVID-19 severity in 9/11 responders. PLoS One. 2023; 18(3):e0282271.
-
"Everything in One Place": Stakeholder Perceptions of Integrated Medical and Social Care for Diabetes Patients in Western Maryland. J Gen Intern Med. 2023 03; 38(Suppl 1):25-32.
-
New Frontiers in Diabetes Care: Quality Improvement Study of a Population Health Team in Rural Critical Access Hospitals. J Gen Intern Med. 2023 03; 38(Suppl 1):56-64.
-
Glycemic Control and Patient-Reported Outcomes Among Patients with Diabetes Engaged with Community Health Workers in Rural Settings. J Gen Intern Med. 2023 03; 38(Suppl 1):45-47.
-
Objective and Subjective Sleep Patterns in Adults With Maturity-Onset Diabetes of the Young (MODY). Diabetes Care. 2023 03 01; 46(3):608-612.
-
Effects of finerenone in people with chronic kidney disease and type 2 diabetes are independent of HbA1c at baseline, HbA1c variability, diabetes duration and insulin use at baseline. Diabetes Obes Metab. 2023 06; 25(6):1512-1522.
-
Kidney outcomes with finerenone: an analysis from the FIGARO-DKD study. Nephrol Dial Transplant. 2023 02 13; 38(2):372-383.
-
Effects of canagliflozin on liver steatosis and fibrosis markers in patients with type 2 diabetes and chronic kidney disease: A post hoc analysis of the CREDENCE trial. Diabetes Obes Metab. 2023 05; 25(5):1413-1418.
-
Finerenone and effects on mortality in chronic kidney disease and type 2 diabetes: a FIDELITY analysis. Eur Heart J Cardiovasc Pharmacother. 2023 02 02; 9(2):183-191.